Back to Newsroom

Auris Medical Provides Business Update and Reports Third Quarter 2016 Financial Results

ZUG, Switzerland, Nov. 10, 2016 (GLOBE NEWSWIRE) — Auris Medical Holding AG (NASDAQ:EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today provided a business update and announced financial results for the third quarter ended Sept. 30, 2016.

Click here to read the full release